Charles Chase is the founder of Elicio Therapeutics. Elicio Therapeutics has raised $136M in total funding. Latest round: Series B. Based in Boston, MA.
Charles Chase serves as the VP - Bus. Development at Elicio Therapeutics, a private and independent biopharmaceutical company based in Cambridge, MA. The company is dedicated to transforming cancer treatment by re-engineering the body's immune response, developing vaccines and immunotherapies for various aggressive cancers.
Full founder directory · Investor directory · Company funding database · Fundraising library